文献速递消化道肿瘤与早癌消化内镜

液氮喷雾冷冻治疗用于无法手术食管癌患者吞咽困难的姑息治疗

Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer.
PubMed 文献 · Gastrointest Endosc · 2018-05-08

这项回顾性、多中心、连续病例系列纳入49例无法手术的食管癌患者,于2014年5月至2016年5月在4家专科癌症中心接受姑息性内镜冷冻治疗,共120次治疗。吞咽困难评分从治疗前2.4显著改善至治疗后1.7(改善0.7分,P < .001),120次治疗中6次(5.0%)出现轻微不良事件。作者认为液氮喷雾冷冻治疗可能安全有效,但需大型前瞻性研究证实。

要点

  • 49例无法手术食管癌患者共接受120次冷冻治疗,吞咽困难评分从2.4改善至1.7(P < .001)。
  • 120次治疗中6次(5.0%)发生轻微不良事件,另各有1例严重术中穿孔和良性狭窄需扩张。
  • 作者认为冷冻治疗可能安全有效,但需大型前瞻性研究确认并识别最大获益的患者与操作特征。

核心结论

  • 这项初步回顾性研究提示,液氮喷雾冷冻治疗用于无法手术食管癌的吞咽困难姑息治疗可能安全有效。
  • 需要大型前瞻性研究来证实这些发现,并识别与最大获益相关的患者和操作特征。

研究设计与样本

  • 回顾性、多中心、连续病例系列,纳入2014年5月至2016年5月在4家专科癌症中心接受姑息性内镜冷冻治疗的49例无法手术食管癌患者。
  • 主要结局为冷冻治疗前后吞咽困难评分变化和不良事件;吞咽困难采用5点Likert量表:0分为无吞咽困难,1分为固体食物吞咽困难,2分为半固体食物吞咽困难,3分为液体吞咽困难,4分为唾液吞咽困难。

主要发现

  • 39例男性和10例女性,平均年龄58岁,共接受120次冷冻治疗。
  • 平均吞咽困难评分从冷冻治疗前2.4显著改善至治疗后1.7(改善0.7分;P < .001)。
  • 120次冷冻治疗中6次(5.0%)出现轻微不良事件(1次术中、5次术后)。
  • 1例患者发生扩张相关穿孔的严重术中不良事件,另1例患者发生需扩张的良性狭窄。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述为初步回顾性研究。
  • 原文结论提出需要大型前瞻性研究来证实这些发现并识别与最大获益相关的患者和操作特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Dysphagia is a debilitating symptom in patients with inoperable esophageal cancer that contributes to poor quality of life and worsening nutritional status. The 2 most commonly used palliative modalities for dysphagia are radiation therapy and esophageal stent placement. However, radiation therapy is limited by adverse events (AEs) and total dose, and stent placement has a high rate of AEs, including reflux, migration, and chest pain. A relatively new modality of liquid nitrogen endoscopic spray cryotherapy has been described as salvage when other options have been exhausted and when patients are no longer receiving systemic therapy. We evaluated the safety and efficacy of cryotherapy as the primary modality for relieving dysphagia in inoperable esophageal cancer including patients receiving systemic cancer therapy. METHODS: This is a retrospective, multicenter, consecutive case series of 49 inoperable esophageal cancer patients undergoing palliative endoscopic cryotherapy at 4 specialized cancer centers from May 2014 to May 2016. The primary outcomes were change in dysphagia scores between pre- and postcryotherapy and AEs. Dysphagia was measured using a 5-point Likert scale: 0, no dysphagia; 1, dysphagia to solids; 2, dysphagia to semisolids; 3, dysphagia to liquids; 4, dysphagia to saliva. RESULTS: Thirty-nine men and 10 women with a mean age of 58 years underwent a total of 120 cryotherapy treatments. The mean dysphagia score improved significantly from 2.4 precryotherapy to 1.7 postcryotherapy (improvement of .7 points; P < .001). Minor AEs were seen in 6 of 120 (5.0%) cryotherapy treatments (1 intraprocedural and 5 postprocedural). In addition, 1 patient developed a severe intraprocedural AE of dilation-related perforation, whereas another patient developed a benign stricture requiring dilation. CONCLUSIONS: This preliminary retrospective study suggests that liquid nitrogen spray cryotherapy may be safe and effective for dysphagia palliation in inoperable esophageal cancer. Large prospective studies are needed to confirm these findings and identify patient and procedure characteristics associated with the greatest benefit.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Kachaamy T, Prakash R, Kundranda M, et al. Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer. Gastrointest Endosc. 2018. PMID: 29750984. doi:10.1016/j.gie.2018.04.2362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。